Corteva (NYSE:CTVA) Issues Quarterly Earnings Results, Beats Estimates By $0.06 EPS

Corteva (NYSE:CTVA) posted its quarterly earnings results on Thursday. The company reported $2.30 earnings per share for the quarter, beating the consensus estimate of $2.24 by $0.06, Zacks reports. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The company had revenue of $6.38 billion during the quarter, compared to analyst estimates of $6.60 billion. During the same quarter in the prior year, the business earned $2.20 earnings per share. The firm’s revenue for the quarter was down 1.2% on a year-over-year basis. Corteva updated its FY 2026 guidance to 3.600-3.800 EPS.

Corteva Stock Performance

CTVA stock traded down $1.12 during midday trading on Thursday, reaching $89.39. 5,561,841 shares of the company’s stock traded hands, compared to its average volume of 3,968,582. The firm has a market capitalization of $59.79 billion, a PE ratio of 52.58, a price-to-earnings-growth ratio of 2.69 and a beta of 0.56. The company has a 50-day moving average price of $81.95 and a two-hundred day moving average price of $79.41. Corteva has a 52 week low of $60.53 and a 52 week high of $90.97. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be issued a dividend of $0.18 per share. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a yield of 0.8%. Corteva’s payout ratio is presently 42.35%.

Institutional Trading of Corteva

Hedge funds and other institutional investors have recently made changes to their positions in the stock. JPL Wealth Management LLC purchased a new stake in Corteva during the 3rd quarter worth about $25,000. Garton & Associates Financial Advisors LLC purchased a new position in Corteva during the 4th quarter valued at about $27,000. Bank of Jackson Hole Trust purchased a new position in Corteva during the 4th quarter valued at about $28,000. Measured Wealth Private Client Group LLC bought a new stake in shares of Corteva during the third quarter valued at about $33,000. Finally, Binnacle Investments Inc increased its position in shares of Corteva by 54.7% during the second quarter. Binnacle Investments Inc now owns 512 shares of the company’s stock valued at $38,000 after buying an additional 181 shares during the period. 81.54% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the stock. Mizuho boosted their target price on shares of Corteva from $96.00 to $97.00 and gave the company an “outperform” rating in a research note on Tuesday, July 14th. BNP Paribas Exane lifted their price target on shares of Corteva from $74.00 to $77.00 in a report on Wednesday, May 6th. Deutsche Bank Aktiengesellschaft upped their price objective on Corteva from $90.00 to $100.00 in a research note on Monday, May 11th. Jefferies Financial Group raised their target price on Corteva from $95.00 to $97.00 in a research report on Thursday, May 7th. Finally, Barclays boosted their target price on Corteva from $84.00 to $91.00 and gave the company an “overweight” rating in a research note on Thursday, June 11th. One analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $90.19.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.